Highridge Medical has completed the sale of its Bone Healing division to Avista Healthcare Partners. This move aims to help the company focus exclusively on its Spine business and enhance long-term growth through increased investment in innovation and commercial capabilities.
The sale proceeds will be directed towards portfolio innovation and expanding the company’s commercial reach. The Bone Healing division, which specializes in non-invasive and implantable therapies for various conditions, will now become an independent entity under Avista Healthcare Partners.
“Divesting the Bone Healing division allows Highridge to further sharpen our focus on our most promising growth opportunities. We are committed to driving innovation in partnership with our surgeon customers to deliver innovative spinal solutions to enhance patient outcomes,” said Rebecca Whitney, CEO of Highridge Medical.
Highridge Medical is a Westminster-based medical device company that seeks to improve spine care by collaborating with surgeons to foster innovation.
